| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 676999 | Null | 0.038506707102734 | 0.3625856 |
| NSC 678049 | Null | 0.038506707102734 | 0.39250473 |
| NSC 678914 | 4-Acridinecarboxamide, N-[2-(dimethylamino)ethyl]- 1-methoxy-, dihydrochloride | 0.038506707102734 | 0.23610324 |
| NSC 680510 | 1,8-Naphthyridin-3-amine, 2,7-dichloro-5-methyl- | 0.038506707102734 | 0.50447706 |
| NSC 680715 | Benzaldehyde, 5-bromo-2-hydroxy- (9CI) | 0.038506707102734 | 0.36506085 |
| NSC 681229 | Boronic acid, [1-[[2-amino-3-(1-naphthalenyl)- 1-oxopropyl]amino]-3-methylbutyl]-, L-(S)-, hydrochloride | 0.038506707102734 | 0.41373972 |
| NSC 684569 | Barbituric acid, 5-[3-(4-methoxyphenyl)- 2-propenylidene]-2-thio- | 0.038506707102734 | 0.43842875 |
| NSC 685126 | 4-Piperidinone, 3,5-bis[(4-fluorophenyl)methylene]-, (E,E)- | 0.038506707102734 | 0.42884706 |
| NSC 690271 | ANTINEOPLASTIC-690271 | 0.038506707102734 | 0.54107083 |
| NSC 69187 | B 656501 K003 | 0.038506707102734 | 0.28908222 |